Molecular Microbiology & Microbial Pathogenesis Seminar Series

Fall 2021

Sep 28Kit PoglianoUCSDHow to build an endospore and accelerate antibiotic drug discoveryScott Hultgren
Oct 5Nancy KellerUniversity of WisconsinAspergillus fumigatus exometabolites mediating Multi-Kingdom interactions at the microbe and host interfaceJeff Henderson & Mary Dinauer
Oct 12Harris WangColumbia UniversityMapping & Modifying the Gut Microbiome in New DimensionsTae Seok Moon
Oct 19Haina ShinWashington University in St. LouisInnate immune control of disease outcomes during mucosal viral infectionSebla Kutluay & Tamara Doering
Oct 26Benhur LeeIcahn School of medicine at Mount SinaiInterferon-silent Sendai virus mediated CRISPR-Cas9 editing in human cellsCarolina Lopez
Nov 2Jeff DvorinHarvard University, Boston Children’sOne ring to rule them all — discovering novel cell biology in malaria parasiteDan Goldberg
Nov 9Ferric FangUniversity of WashingtonPathogenesis of Enteric FeverMary Dinauer & Jeff Henderson
Nov 16Alexander PlossPrinceton UniversityLooking under the hood of a killer virus: new insights into the molecular biology of hepatitis B virusLiang Shan
Nov 23Margaret A. ScullUniversity of MarylandAt the Interface: Influenza Virus – Mucin Interactions in the AirwayGaya Amarasinghe
Nov 30David RosenWashington University in St. LouisKlebsiella pneumoniae:  Formidable Foe Necessitating a Multipronged Approach
Dec 7Rob KnightUC San DiegoScaling microbiome analyses to millions of samplesOlivia Gorushi, Student

Spring 2021

Jan 12Nir DraymanThe University of ChicagoSingle Cell Virology (and drug repurposing efforts against SARS-CoV-2)Carolina Lopez
Jan 19Mary EstesBaylor College of MedicineTranslating Stem Cell Biology to Understand Human Gastrointestinal InfectionsSiyuan Ding
Jan 26Anna KuchinaUniversity of WashingtonExploring microbial phenotypic diversity with single-cell RNA sequencingChristina Stallings
Feb 2Jacob YountOhio State UniversityBeneficial and detrimental effects of type I interferons in virus infectionsCarolina Lopez
Feb 9Kevin ForsbergFred Hutchinson Cancer Research CenterThe Hidden World of CRISPR-Cas InhibitorsMichael Caparon
Feb 16Thierry DiaganaNovartisDiscovery and advancement of new drugs for malaria and neglected tropical diseasesDavid Sibley
Feb 23Filipa Rijo-FerreiraUT SouthwesternCircadian rhythms in parasitic diseases: an underlying clock of malaria parasitesDavid Sibley
Mar 2Natacha RuizOhio State UniversityPriority shipping: sending building blocks to the outer membraneMichael Caparon
Mar 9Eleftherios “Lefteris” MichailidisThe Rockefeller UniversityModeling chronic hepatitis B infections in hepatocyte systemsCarolina Lopez
Mar 16Boyuan WangMITRegulation of Metabolism and Viability of Bacteria by the Nucleotides (p)ppGpp and (p)ppAppChristina Stallings
Mar 23Matthew ChapmanUniversity of MichiganPolymerizing the Fiber Between Functional Amyloids and Pathogenic Neurodegenerative DiseaseScott Hultgren
Mar 30Jason McClellanSean Whelan
Apr 6Philip KranzuschHarvard Medical SchoolcGAS-like enzymes in immunity and host-microbe signalingSean Whelan
Apr 13James CollinsUT SouthwesternSex, drugs, and worms: developing a better understanding of schistosome biology to advance new therapiesChristina Stallings
Apr 20Tobi Spielmann Bernhard Nocht Institute for Tropical Medicine, HamburgInfluence of nutrient access on drug action and resistance in malaria parasites Dan Goldberg
Apr 27Clare SmithDuke UniversityA host-pathogen genetic map of tuberculosis susceptibilityShabaana Khader
May 4John WhitneyMcMaster UniversityMolecular Basis for Chaperone Assisted Loading of Antibacterial Toxins onto a Bacterial NanomachineMario Feldman